(19)
(11) EP 4 146 690 A1

(12)

(43) Date of publication:
15.03.2023 Bulletin 2023/11

(21) Application number: 21729694.6

(22) Date of filing: 07.05.2021
(51) International Patent Classification (IPC): 
C07K 16/10(2006.01)
A61K 39/395(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/10; A61K 2039/505; A61K 2039/507; A61P 31/14; C07K 2317/21; C07K 2317/76; C07K 2317/92
(86) International application number:
PCT/US2021/031442
(87) International publication number:
WO 2021/226560 (11.11.2021 Gazette 2021/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.05.2020 US 202063022392 P
13.05.2020 US 202063024372 P
20.05.2020 US 202063027814 P
22.05.2020 US 202063029338 P
28.05.2020 US 202063031286 P
01.06.2020 US 202063033045 P
09.06.2020 US 202063036683 P
16.06.2020 US 202063039939 P
30.06.2020 US 202063046465 P
28.07.2020 US 202063057767 P
12.10.2020 US 202063090667 P
13.11.2020 US 202063113450 P
25.02.2021 US 202163153784 P
02.04.2021 US 202163170368 P

(71) Applicant: VIR Biotechnology, Inc.
San Francisco, CA 94158 (US)

(72) Inventors:
  • CORTI, Davide
    6500 Bellinzona (CH)
  • PIZZUTO, Matteo Samuele
    6500 Bellinzona (CH)
  • PINTO, Dora
    6500 Bellinzona (CH)
  • BELTRAMELLO, Martina
    6500 Bellinzona (CH)
  • DE MARCO, Anna
    6500 Bellinzona (CH)
  • CAMERONI, Elisabetta
    6500 Bellinzona (CH)
  • SNELL, Gyorgy
    San Francisco, CA 94158 (US)
  • CZUDNOCHOWSKI, Nadine
    San Francisco, CA 94158 (US)
  • HAVENAR-DAUGHTON, Colin
    San Francisco, CA 94158 (US)
  • LEMPP, Florian A.
    San Francisco, CA 94158 (US)
  • TELENTI, Amalio
    San Francisco, CA 94158 (US)
  • ZATTA, Fabrizia
    6500 Bellinzona (CH)

(74) Representative: Graf von Stosch Patentanwaltsgesellschaft mbH 
Prinzregentenstraße 22
80538 München
80538 München (DE)

   


(54) ANTIBODIES AGAINST SARS-COV-2